Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments.
Moreno-Vicente J, Willoughby JE, Taylor MC, Booth SG, English VL, Williams EL, Penfold CA, Mockridge CI, Inzhelevskaya T, Kim J, Chan HTC, Cragg MS, Gray JC, Beers SA.
Moreno-Vicente J, et al. Among authors: taylor mc.
J Immunother Cancer. 2022 Jan;10(1):e003735. doi: 10.1136/jitc-2021-003735.
J Immunother Cancer. 2022.
PMID: 35017153
Free PMC article.